Evolution Advisers, Inc.

SEC CIK: 0001906967
Latest filing: Jul 31, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Evolution Advisers, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2026): 1
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2023

Holdings of VRTX by Evolution Advisers, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	1	$0	0.0%	+1	New	Holders
Q3 2023	0	$0	0.0%	−4−100.0%	Sold out	Holders
Q2 2023	4	$1.00K	<0.1%	00.0%	Unchanged	Holders
Q1 2023	4	$1.00K	<0.1%	+4	New	Holders